Assessing the Real-World Inpatient Treatment Paradigm for Recurrent Clostridium Difficile

Home / Intelligence / Scientific Publications / Assessing the Real-World Inpatient Treatment Paradigm for Recurrent Clostridium Difficile

This analysis of real-world hospital data aimed to characterize the treatment regimens for inpatients experiencing rCDI, including both hospital- and community-acquired recurrence, and to compare these regimens to current treatment guidelines.

Authors

Gavin Miyasato, Hannah Li, Dushyant Katariya, Kevin Francis, Nandini Hadker

Journal

ISPOR Meeting; May 2020

View publication

Related Intelligence

Scientific Publications

Treatment preferences among health care providers in the United States in selecting disease modifying therapies for multiple sclerosis: a discrete choice experiment study

Autoimmune screening panel (ASP) is routinely ordered as a part of diagnostic work-up in people with suspected multiple sclerosis (MS). However, data on prevalence and significance of ASP seropositivity in MS is scarce.

Scientific Publications

Burden of cremophor-related paclitaxel therapy on patients with ovarian cancer: A patient focused study from the United Kingdom, Germany, and Spain.

This study aimed to characterize the burden associated with CrEL-paclitaxel treatment on patients with ovarian cancer, including clinical, safety, and quality of life implications.

Scientific Publications

Evaluating the Clinical, Economic, and Societal Value of Rapid Diagnostic Testing in Emerging Markets: A Systematic Literature Review Assessing Infectious Diseases

This study aimed to synthesize published and other literature on the clinical, societal, and economic value of RDTs for infectious disease across Asia, Africa, and Latin America.